MedPath

Quality of Life Assessment Between Internal Endoscopic Versus Percutaneous Drainage in Biliary Obstruction

Recruiting
Conditions
Biliary Obstruction
Registration Number
NCT04857424
Lead Sponsor
Mayo Clinic
Brief Summary

The aim of this study is to compare the quality of life in subjects with benign and malignant biliary obstruction who have or will undergo endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous trans-hepatic biliary drainage (PTBD).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
206
Inclusion Criteria
  • Patients with benign biliary obstruction
  • Patients with malignant biliary obstruction
  • Patients undergoing ERCP and/or PTBD
Read More
Exclusion Criteria
  • Patients with gallstone disease
  • Patients who will undergo ERCP who have previously underwent a PTBD
  • Patients who will undergo PTBD who have previously underwent an ERCP
  • Female patients who are pregnant
  • Prisoners and other vulnerable populations
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in European Quality of Life-5 Dimensions questionnaire scoreBaseline, 1 month, 3 months

Measured using the European Quality of Life-5 Dimensions questionnaire that measures mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The Euro-QOL-5D score is derived from adding the scores from each of the five items. The best possible score is five (i.e., asymptomatic in each item) and the worst possible score is 15 (incapacitated in each item).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath